Proteomic-based stratification of intermediate-risk prostate cancer patients

Name: Proteomic-based stratification of intermediate-risk prostate cancer patients
Creator: CMRI, USYD
Published: 2023-01-01T00:00:00+08:00

Harvard Dataverse2023-03-05 更新2026-04-09 收录

蛋白质组学预后分层

前列腺癌精准医疗

数据链接：

https://dataverse.harvard.edu/citation?persistentId=doi:10.7910/DVN/1RORIX 数据链接链接失效反馈

官方服务：

资源简介：

Clinical and survival data for 198 patients from a cohort of 290 patients.

提供机构：

CMRI, USYD

创建时间：

2023-01-01

Patient-matched analysis identifies deregulated networks in prostate cancer to guide personalized therapeutic intervention

前列腺癌精准医疗

调控网络靶点识别

Prostate cancer (PrCa) is the second most common malignancy in men. More than 50% of advanced prostate cancers display the TMPRSS2-ERG fusion. Despite extensive cancer genome/transcriptome data, littl

NIAID Data Ecosystem50

Tissue-based biomarkers in prostate cancer

前列腺癌精准医疗

组织生物标志物验证

Introduction: Prostate cancer is a heterogeneous disease. Existing risk stratification tools based on standard clinlicopathologic variables (prostate specific antigen [PSA], Gleason score, and tumor s

Figshare2017-10-31 更新20

Supplementary Table 1 from Novel Afro-Caribbean Prostate Cancer Model Reveals Ancestry-Specific Drug Vulnerabilities with Therapeutic Implications for Black Patients

前列腺癌精准医疗

药物靶点发现

DEGs in ACRJ-PC28 vs Other PCa. This table presents the complete list of 1396 differentially expressed genes (DEGs) identified when comparing the novel Afro-Caribbean ACRJ-PC28 cell line against all o

NIAID Data Ecosystem10

File S3 from Circulating Tumor Cell Genomic Evolution and Hormone Therapy Outcomes in Men with Metastatic Castration-Resistant Prostate Cancer

癌症基因组数据

前列腺癌精准医疗

Top somatic COSMIC variations were compared between 11 baselines and matched post-treatment CTC-DNA of mCRPC patients. Matched WBC DNA has been used as a reference control for somatic mutation. All th

Figshare2021-06-01 更新40

Table1_Identification of Neoantigens and Construction of Immune Subtypes in Prostate Adenocarcinoma.XLSX

肿瘤免疫治疗

前列腺癌精准医疗

Background: Messenger ribonucleic acid (mRNA) vaccine has been considered as a potential therapeutic strategy and the next research hotspot, but their efficacy against prostate adenocarcinoma (PRAD) r

NIAID Data Ecosystem20

Proteomic-based stratification of intermediate-risk prostate cancer patients

资源简介：

相关数据集